ALLMEDTECH.COM
ALLMEDTECH.COM
MEDICAL, SURGICAL, DENTAL,
PHARMACEUTICALS , OBGYN,
VETERINARY & PET SUPPLIES,
DIAGNOSTIC LAB, COSMETICS,
VACCINES , INJECTABLES , IV ,
GENERIC & OTC MEDICATIONS ,
PHARMACY'S AND MED-SPORT
SUPPLIES & EQUIPMENTS
TOLL FREE: 1-800-939-6944
Immunocidin Mycobacterium
Cell Wall Fraction Immunostimulant,
2.5mL
Vedco FR11-4800
Cell Wall Fraction Immunostimulant,
2.5mL
Vedco FR11-4800
Product Description
Immunocidin Mycobacterium
Cell Wall Fraction Immunostimulant,
2.5mL
Vedco FR11-4800
Specifications Volume: 2.5 ml Package Quantity: 1/Pkg Presentation: Liquid Container Type: Vial Delivery Type: Injection Reconstitution Required: N Biological Type: Undefined Product Details A veterinary biologic for the treatment of mixed mammary tumor and mammary adenocarcinoma in dogs.
An emulsion of mycobacterium cell wall fractions which have been modified to reduce their toxic and allergic effect but retain their antitumor activity Safely treats canine mammary cancer alone or in combination with surgery Administered by intratumoral injection, with a generalized response where untreated sites frequently undergo regression as well High tumor-free survival rate A treatment option for dogs that are poor surgical risks Minimizes side effects associated with chemotherapeutic treatments May be used safely in-clinic with no risk to clinic personnel An economical treatment option for your clients Excellent safety profile for the patient
This item could be sold only to specialists with valid license
Cell Wall Fraction Immunostimulant,
2.5mL
Vedco FR11-4800
Specifications Volume: 2.5 ml Package Quantity: 1/Pkg Presentation: Liquid Container Type: Vial Delivery Type: Injection Reconstitution Required: N Biological Type: Undefined Product Details A veterinary biologic for the treatment of mixed mammary tumor and mammary adenocarcinoma in dogs.
An emulsion of mycobacterium cell wall fractions which have been modified to reduce their toxic and allergic effect but retain their antitumor activity Safely treats canine mammary cancer alone or in combination with surgery Administered by intratumoral injection, with a generalized response where untreated sites frequently undergo regression as well High tumor-free survival rate A treatment option for dogs that are poor surgical risks Minimizes side effects associated with chemotherapeutic treatments May be used safely in-clinic with no risk to clinic personnel An economical treatment option for your clients Excellent safety profile for the patient
This item could be sold only to specialists with valid license